Related Experiment Video
Updated: Apr 21, 2026

Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability
Published on: August 6, 2021
Central retinal vein occlusion in a young adult during risperidone therapy
Alper Ağca1, Zerrin Bayraktar, Mehmet Cakr
1From *Beyoğlu Eye Research and Education Hospital, Eye Clinic; and †Marmara University Medical Faculty, School of Medicine, Department of Child and Adolescent Psychiatry, Istanbul, Turkey.
Background:
Various articles in the literature point out the higher risk of venous thrombosis in patients taking antipsychotic drugs. However, to our knowledge, an association with central retinal vein occlusion (CRVO) has not been reported before.
Methods:
We describe the clinical and angiographic findings of a patient with CRVO that may have been related to his antipsychotic medication.
Results:
A 19-year-old patient had been taking risperidone and fluoxetine for the last 7 months. He presented with atypical nonischemic CRVO with atypical deep intraretinal hemorrhages, a swollen optic disk, dilatation and engorgement of retinal veins, and optic disk capillaries. Despite a detailed workup, no systemic or ocular risk factors for a thromboembolic event were found. He had hyperprolactinemia resulting from his medication.
Conclusion:
The use of risperidone may be a risk factor for CRVO.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Diabetic Retinopathy
Angle Closure Glaucoma: Treatment
Glaucoma: Overview
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis I: Introduction

